Greg S. Yap
Director/Board Member at Outward Bound California
Profile
Greg is a partner at Menlo Ventures, where he invests in teams trying to solve major problems in life science and healthcare, with a special interest in novel therapeutic platforms, digital health, and transformative technologies.
Since joining in 2017, Greg has led Menlo’s investments in Clear Labs, Delfi Diagnostics, Encoded Therapeutics, Epiodyne, Genesis Therapeutics, H1 Insights, Ophelia Health, Particle Health, Pliant Therapeutics (NASDAQ: PLRX), Senti Biosciences, Scribe Therapeutics and Riva Health.
He has also been involved in investments in Benchling, Recursion Pharmaceuticals, and Cofactor Genomics.
Previously, Greg was at Illumina Ventures as entrepreneur-in-residence, where he focused on new investments related to genomics.
Prior to entering venture capital, Greg had 20 years of experience in senior executive and entrepreneurial roles in life science and digital health.
He was CEO and co-founder of two startups: BlueLight Therapeutics (originally Biodesy), a structure- driven platform & therapeutics company, and PyrAmes, a digital health remote monitoring company.
At Roche Diagnostics/Ventana, Greg led a global market-leading cancer diagnostic assay business, serving 20 million patients and delivering $500 million revenue per year.
Greg’s operating experience also includes roles as the first healthcare entrepreneur-in-residence at GE; chief operating officer at Cellpoint Diagnostics, an early liquid biopsy startup; vice president and general manager for genetics and molecular diagnostics at Affymetrix, the microarray genomics pioneer; and consultant for McKinsey & Company.
Greg received his bachelor’s degree in molecular biology (summa cum laude) from Princeton University and his MBA from Stanford University’s Graduate School of Business.
He is an Aspen Health Innovators Fellow and a member of the Aspen Global Leadership Network.
Greg is a Bay Area native and has lived in 11 cities in the area.
Greg serves on the board of Outward Bound California.
Greg S. Yap active positions
| Companies | Position | Start |
|---|---|---|
| Outward Bound California | Director/Board Member | 2013-07-31 |
Menlo Ventures Management LP
 Menlo Ventures Management LP Investment ManagersFinance Menlo Ventures Management LP (Menlo Ventures) is a venture capital firm founded in 1976 by DuBose Montgomery. The firm is headquartered in San Francisco, California. | Private Equity Investor | 2017-09-30 |
Clear Labs, Inc.
 Clear Labs, Inc. Food: Major DiversifiedConsumer Non-Durables Clear Labs, Inc. provides services related to food quality. The firm offers clear view platform, GMO test and WGS test products. The company was founded by Sasan Amini and Mahni Ghorashi in 2014 and is headquartered in San Carlos, CA. | Director/Board Member | 2018-12-31 |
Particle Health, Inc.
 Particle Health, Inc. Internet Software/ServicesTechnology Services Particle Health, Inc. operates as a health care platform. The company was founded by Troy Bannister and Dan Horbatt in 2018 and is headquartered in New York, NY. | Director/Board Member | 2020-04-27 |
Riva Health, Inc.
 Riva Health, Inc. Packaged SoftwareTechnology Services Vital Labs, Inc. operates as a digital therapeutics platform. It offers medical image processing, data analytics, and consumer facing product development. The company was founded by Ian Eslick, Tuhin Sinha, and Doug Barry on May 2, 2014 and is headquartered in Burlingame, CA. | Director/Board Member | 2018-12-31 |
H1 Insights, Inc.
 H1 Insights, Inc. Internet Software/ServicesTechnology Services H1 Insights, Inc. operates as a platform for healthcare ecosystem. The company was founded by Ariel Katz and Ian Sax and is headquartered in New York, NY. | Director/Board Member | 2019-12-31 |
Delfi Diagnostics, Inc.
 Delfi Diagnostics, Inc. Medical/Nursing ServicesHealth Services Delfi Diagnostics, Inc. engages in the development of blood test for detection and interception of cancer. It uses artificial intelligence and whole genome sequencing to detect patterns of DNA fragmentation in the blood of patients with cancer. The company is headquartered in Baltimore, MD. | Director/Board Member | 2018-12-31 |
Epiodyne, Inc.
 Epiodyne, Inc. Pharmaceuticals: MajorHealth Technology Epiodyne, Inc. engages in biotechnology services. The company was founded by Brian Shoichet, Brian Kobilka, Peter Gmeiner, Bryan L. Roth, Gregory Scherrer, and Aashish Manglik in 2016 and is headquartered in San Francisco, CA. | Director/Board Member | 2017-12-31 |
Mission Bay Capital Management, Inc.
 Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital Management Inc (Mission Bay Capital) is a venture capital firm founded in 2009. The firm is headquartered in San Francisco, California. | Consultant / Advisor | - |
| ░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Former positions of Greg S. Yap
| Companies | Position | End |
|---|---|---|
| ░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░░ ░░ ░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
| ░░░ ░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Greg S. Yap
| Stanford University | Masters Business Admin |
| Princeton University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| GE AEROSPACE | Producer Manufacturing |
| ROCHE HOLDING AG | Health Technology |
| Private companies | 17 |
|---|---|
Affymetrix, Inc.
 Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA. | Health Technology |
Ventana Medical Systems, Inc.
 Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Electronic Technology |
Cellective Dx Corp.
 Cellective Dx Corp. Pharmaceuticals: GenericHealth Technology Informed decisions will improve the way cancer is treated. On-Q-ity is an innovative diagnostic company that is focused on providing physicians with the tools they need to make the best decision when treating individual cancer patients. Its platform will enable better decision-making across multiple cancers: improving the cost of treatment, the quality of life for patients and ultimately increasing survival. Products currently in development are based on two core technologies: 1) DNA repair biomarkers that predict treatment response and 2) Microfluidic chip technology that enables capture, enumeration and characterization of circulating tumor cells (CTCs) in the bloodstream. | Health Technology |
BlueLight Therapeutics, Inc.
 BlueLight Therapeutics, Inc. BiotechnologyHealth Technology BlueLight Therapeutics, Inc. develops novel systems to analyze real-time protein function for research and clinical applications. The firm offers technology for detecting conformational change in proteins and other biological molecules. Its technology is based on a phenomenon called second-harmonic generation (SHG), can monitor structural changes at any site within a protein, in real time and since protein function is determined by its structure, and changes in structure cause changes in function, characterizing these changes will provide significant insights into how the body functions and respond to treatments. The company was founded by Joshua S. Salafsky and Greg S. Yap in 2013 and is headquartered in South San Francisco, CA. | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Menlo Ventures Management LP
Menlo Ventures Management LP Investment ManagersFinance Menlo Ventures Management LP (Menlo Ventures) is a venture capital firm founded in 1976 by DuBose Montgomery. The firm is headquartered in San Francisco, California. | Finance |
Bay City Capital LLC
 Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Finance |
Mission Bay Capital Management, Inc.
Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital Management Inc (Mission Bay Capital) is a venture capital firm founded in 2009. The firm is headquartered in San Francisco, California. | Finance |
| Outward Bound California | |
Clear Labs, Inc.
Clear Labs, Inc. Food: Major DiversifiedConsumer Non-Durables Clear Labs, Inc. provides services related to food quality. The firm offers clear view platform, GMO test and WGS test products. The company was founded by Sasan Amini and Mahni Ghorashi in 2014 and is headquartered in San Carlos, CA. | Consumer Non-Durables |
Epiodyne, Inc.
Epiodyne, Inc. Pharmaceuticals: MajorHealth Technology Epiodyne, Inc. engages in biotechnology services. The company was founded by Brian Shoichet, Brian Kobilka, Peter Gmeiner, Bryan L. Roth, Gregory Scherrer, and Aashish Manglik in 2016 and is headquartered in San Francisco, CA. | Health Technology |
Particle Health, Inc.
Particle Health, Inc. Internet Software/ServicesTechnology Services Particle Health, Inc. operates as a health care platform. The company was founded by Troy Bannister and Dan Horbatt in 2018 and is headquartered in New York, NY. | Technology Services |
Delfi Diagnostics, Inc.
Delfi Diagnostics, Inc. Medical/Nursing ServicesHealth Services Delfi Diagnostics, Inc. engages in the development of blood test for detection and interception of cancer. It uses artificial intelligence and whole genome sequencing to detect patterns of DNA fragmentation in the blood of patients with cancer. The company is headquartered in Baltimore, MD. | Health Services |
PyrAmes, Inc.
 PyrAmes, Inc. Electronic Equipment/InstrumentsElectronic Technology PyrAmes, Inc. develops blood pressure monitoring equipment. The company was founded by Xina Quan and Zhenan Bao in 2016 and is headquartered in Cupertino, CA. | Electronic Technology |
Ophelia Health, Inc.
 Ophelia Health, Inc. Medical/Nursing ServicesHealth Services Ophelia Health, Inc. provides healthcare services. The company was founded by Zack Gray and Mattan Griffel and is headquartered in New York, NY. | Health Services |
H1 Insights, Inc.
H1 Insights, Inc. Internet Software/ServicesTechnology Services H1 Insights, Inc. operates as a platform for healthcare ecosystem. The company was founded by Ariel Katz and Ian Sax and is headquartered in New York, NY. | Technology Services |
Riva Health, Inc.
Riva Health, Inc. Packaged SoftwareTechnology Services Vital Labs, Inc. operates as a digital therapeutics platform. It offers medical image processing, data analytics, and consumer facing product development. The company was founded by Ian Eslick, Tuhin Sinha, and Doug Barry on May 2, 2014 and is headquartered in Burlingame, CA. | Technology Services |
- Stock Market
- Insiders
- Greg S. Yap
